{"id":347278,"date":"2026-11-14T20:29:29","date_gmt":"2026-11-14T14:59:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/orchid-pharma-q2-results-fy27-pat-29-crore\/"},"modified":"2026-11-14T20:29:29","modified_gmt":"2026-11-14T14:59:29","slug":"orchid-pharma-q2-results-fy27-pat-29-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/orchid-pharma-q2-results-fy27-pat-29-crore\/","title":{"rendered":"Orchid Pharma Q2 Results FY27: Net Profit Rs 28.59 Cr Against Loss, Revenue Rs 341.27 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Orchid Pharma Q2 Results FY27 were declared on 14 November 2026 on a Consolidated basis. In these quarterly results, revenue grew 76.35% YoY to Rs 341.27 Cr from Rs 193.52 Cr, and net profit came in at Rs 28.59 Cr against a loss of Rs 5.72 Cr a year earlier. The YoY growth in net profit is recorded at 599.83% in the filing data.<\/p>\n<\/div>\n

Orchid Pharma Ltd<\/a> (ORCHPHARMA) Q2 Results FY27 announced on 14 November 2026, covering the company’s financial performance for the July to September quarter. The results date brings Orchid Pharma Q2 Results FY27 with consolidated results showing revenue of Rs 341.27 Cr and net profit (PAT) of Rs 28.59 Cr, compared with a loss in the same quarter last year.<\/p>\n

This results analysis of Orchid Pharma Q2 Results covers the financial highlights, business drivers, outlook and risks, based on the filing declared on 14 November 2026. The Financial Highlights section that follows lists the full numbers, and the Univest Screener carries the same lines for ORCHPHARMA.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n